IDEAYA Biosciences (IDYA) Operating Leases (2019 - 2026)

IDEAYA Biosciences has disclosed Operating Leases across 8 years of filings, most recently posting $28.2 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $28.2 million, up 10.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.2 million (up 10.09% YoY), and the FY2025 annual result was $27.6 million, up 46.11% from the prior year.
• Operating Leases came in at $28.2 million for Q1 2026 at IDEAYA Biosciences, up from $27.6 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $28.2 million in Q1 2026 to a low of $611000.0 in Q2 2023.
• The 5-year median for Operating Leases is $2.8 million (2022), against an average of $11.7 million.
• Across the five-year window, Operating Leases plunged 76.24% in 2023 and soared 1980.68% in 2025, its largest moves.
• IDEAYA Biosciences' Operating Leases stood at $1.6 million in 2022, then tumbled by 30.17% to $1.1 million in 2023, then soared by 1577.6% to $18.9 million in 2024, then soared by 46.11% to $27.6 million in 2025, then gained by 2.45% to $28.2 million in 2026.
• The last three Operating Leases figures came in at $28.2 million (Q1 2026), $27.6 million (Q4 2025), and $26.9 million (Q3 2025), per Business Quant data.